NCT05857995 Precision Lung Cancer Survivorship Care Intervention
| NCT ID | NCT05857995 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jerod L Stapleton, PhD |
| Condition | Lung Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-08-16 |
| Primary Completion | 2027-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2024-08-16 with a primary completion date of 2027-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overarching goal of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program is to reduce the burden of lung cancer by offering an innovative survivorship care approach that improves lung cancer quality of life, overcomes lung cancer stigma, and helps survivors engage with care. The project involves a two-group parallel randomized clinical trial comparing the impact of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program (KLCLCSC) among lung cancer survivors (N=300) against an enhanced usual care condition (bibliotherapy+assessment) on quality of life outcomes.
Eligibility Criteria
Inclusion Criteria: * Have been diagnosed with lung cancer * Reside in a rural county as determined by a Rural Urban Continuum Code (RUC) of 4 or higher * Be at least 18 years of age or older * Be able to communicate effectively in English Exclusion Criteria: * Have significant psychiatric disturbance that requires a higher level of care * Have substance abuse/dependence that requires a higher level of care * Are participating in another lung cancer survivorship care intervention * Have previously participated in the Kentucky LEADS Lung Cancer Survivorship Care Program
Contact & Investigator
Jamie L Studts, PhD
PRINCIPAL INVESTIGATOR
University of Colorado School of Medicine
Frequently Asked Questions
Who can join the NCT05857995 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05857995 currently recruiting?
Yes, NCT05857995 is actively recruiting participants. Contact the research team at jerod.stapleton@uky.edu for enrollment information.
Where is the NCT05857995 trial being conducted?
This trial is being conducted at Lexington, United States.
Who is sponsoring the NCT05857995 clinical trial?
NCT05857995 is sponsored by Jerod L Stapleton, PhD. The principal investigator is Jamie L Studts, PhD at University of Colorado School of Medicine. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.